Literature DB >> 22624877

Recruitment and dynamics of proteasome association with rhTRIM5α cytoplasmic complexes during HIV-1 infection.

Cindy M Danielson1, Gianguido C Cianci, Thomas J Hope.   

Abstract

A variety of proteins have been identified that restrict infection by different viruses. One such restriction factor is the rhesus macaque variant of TRIM5α (rhTRIM5α), which potently blocks infection by HIV-1. The block to infection mediated by rhTRIM5α occurs early after entry into the host cell, generally prior to reverse transcription. However, proteasome inhibitors reveal an intermediate step of restriction in which virus can complete reverse transcription, but still fails to infect the cell. While proteasome inhibitors have been a useful tool in understanding how restriction takes place, the role of the proteasome itself during restriction has not yet been examined. Here, we characterize the interaction of rhTRIM5α and incoming virions with the proteasome. We show that proteasomes localize to rhTRIM5α cytoplasmic bodies, and this localization is more evident when the activity of the proteasome is inhibited pharmacologically. We also show that restricted virus associates with complexes of proteasomes and rhTRIM5α, suggesting that rhTRIM5α utilizes the proteasome during restriction. Finally, live cell imaging experiments reveal that virus associates with proteasomes, and proteasome inhibition affects the duration of association. Taken together, these studies implicate the proteasome as playing a functional role during rhTRIM5α restriction of incoming virions.
© 2012 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22624877      PMCID: PMC3760259          DOI: 10.1111/j.1600-0854.2012.01381.x

Source DB:  PubMed          Journal:  Traffic        ISSN: 1398-9219            Impact factor:   6.215


  48 in total

Review 1.  The 26S proteasome: a molecular machine designed for controlled proteolysis.

Authors:  D Voges; P Zwickl; W Baumeister
Journal:  Annu Rev Biochem       Date:  1999       Impact factor: 23.643

2.  Proteasome inhibition reveals that a functional preintegration complex intermediate can be generated during restriction by diverse TRIM5 proteins.

Authors:  Jenny L Anderson; Edward M Campbell; Xiaolu Wu; Nick Vandegraaff; Alan Engelman; Thomas J Hope
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

3.  Alpha interferon enhances TRIM5alpha-mediated antiviral activities in human and rhesus monkey cells.

Authors:  Ryuta Sakuma; Amber A Mael; Yasuhiro Ikeda
Journal:  J Virol       Date:  2007-07-03       Impact factor: 5.103

4.  Antiviral activity of the proteasome on incoming human immunodeficiency virus type 1.

Authors:  O Schwartz; V Maréchal; B Friguet; F Arenzana-Seisdedos; J M Heard
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

Review 5.  Near-field microscopy: throwing light on the nanoworld.

Authors:  David Richards
Journal:  Philos Trans A Math Phys Eng Sci       Date:  2003-12-15       Impact factor: 4.226

6.  A dominant block to HIV-1 replication at reverse transcription in simian cells.

Authors:  Carsten Münk; Stephanie M Brandt; Ginger Lucero; Nathaniel R Landau
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-04       Impact factor: 11.205

7.  Biochemical characterization of a recombinant TRIM5alpha protein that restricts human immunodeficiency virus type 1 replication.

Authors:  Charles R Langelier; Virginie Sandrin; Debra M Eckert; Devin E Christensen; Viswanathan Chandrasekaran; Steven L Alam; Christopher Aiken; John C Olsen; Alak Kanti Kar; Joseph G Sodroski; Wesley I Sundquist
Journal:  J Virol       Date:  2008-09-17       Impact factor: 5.103

8.  The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys.

Authors:  Matthew Stremlau; Christopher M Owens; Michel J Perron; Michael Kiessling; Patrick Autissier; Joseph Sodroski
Journal:  Nature       Date:  2004-02-26       Impact factor: 49.962

9.  Visualization of the intracellular behavior of HIV in living cells.

Authors:  David McDonald; Marie A Vodicka; Ginger Lucero; Tatyana M Svitkina; Gary G Borisy; Michael Emerman; Thomas J Hope
Journal:  J Cell Biol       Date:  2002-11-04       Impact factor: 10.539

10.  TRIM5 alpha cytoplasmic bodies are highly dynamic structures.

Authors:  Edward M Campbell; Mark P Dodding; Melvyn W Yap; Xiaolu Wu; Sarah Gallois-Montbrun; Michael H Malim; Jonathan P Stoye; Thomas J Hope
Journal:  Mol Biol Cell       Date:  2007-03-28       Impact factor: 4.138

View more
  16 in total

1.  Functional evidence for the involvement of microtubules and dynein motor complexes in TRIM5α-mediated restriction of retroviruses.

Authors:  Paulina Pawlica; Valerie Le Sage; Nolwenn Poccardi; Michel J Tremblay; Andrew J Mouland; Lionel Berthoux
Journal:  J Virol       Date:  2014-03-05       Impact factor: 5.103

Review 2.  Control of HIV infection by IFN-α: implications for latency and a cure.

Authors:  Nollaig M Bourke; Silvia Napoletano; Ciaran Bannan; Suaad Ahmed; Colm Bergin; Áine McKnight; Nigel J Stevenson
Journal:  Cell Mol Life Sci       Date:  2017-10-07       Impact factor: 9.261

Review 3.  Restriction of HIV-1 and other retroviruses by TRIM5.

Authors:  Barbie K Ganser-Pornillos; Owen Pornillos
Journal:  Nat Rev Microbiol       Date:  2019-07-16       Impact factor: 60.633

4.  Using antiubiquitin antibodies to probe the ubiquitination state within rhTRIM5α cytoplasmic bodies.

Authors:  Cindy M Danielson; Thomas J Hope
Journal:  AIDS Res Hum Retroviruses       Date:  2013-07-26       Impact factor: 2.205

5.  Knockdown of TRIM5α or TRIM11 increases lentiviral vector transduction efficiency of human Muller cells.

Authors:  Monica M Sauter; Curtis R Brandt
Journal:  Exp Eye Res       Date:  2021-01-10       Impact factor: 3.467

6.  Potent restriction of HIV-1 and SIVmac239 replication by African green monkey TRIM5α.

Authors:  Lori V Coren; Matthew T Trivett; Sumiti Jain; Victor I Ayala; Gregory Q Del Prete; Claes Ohlen; David E Ott
Journal:  Retrovirology       Date:  2015-02-07       Impact factor: 4.602

7.  TRIM5α requires Ube2W to anchor Lys63-linked ubiquitin chains and restrict reverse transcription.

Authors:  Adam J Fletcher; Devin E Christensen; Chad Nelson; Choon Ping Tan; Torsten Schaller; Paul J Lehner; Wesley I Sundquist; Greg J Towers
Journal:  EMBO J       Date:  2015-06-22       Impact factor: 11.598

Review 8.  Viral and cellular requirements for the nuclear entry of retroviral preintegration nucleoprotein complexes.

Authors:  Kenneth A Matreyek; Alan Engelman
Journal:  Viruses       Date:  2013-10-07       Impact factor: 5.048

9.  SJP-L-5, a novel small-molecule compound, inhibits HIV-1 infection by blocking viral DNA nuclear entry.

Authors:  Ru Bai; Xing-Jie Zhang; Yan-Li Li; Jing-Ping Liu; Hong-Bin Zhang; Wei-Lie Xiao; Jian-Xin Pu; Han-Dong Sun; Yong-Tang Zheng; Li-Xin Liu
Journal:  BMC Microbiol       Date:  2015-12-02       Impact factor: 3.605

10.  Primate TRIM5 proteins form hexagonal nets on HIV-1 capsids.

Authors:  Yen-Li Li; Viswanathan Chandrasekaran; Stephen D Carter; Cora L Woodward; Devin E Christensen; Kelly A Dryden; Owen Pornillos; Mark Yeager; Barbie K Ganser-Pornillos; Grant J Jensen; Wesley I Sundquist
Journal:  Elife       Date:  2016-06-02       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.